Breaking News: Moderna Vaccine Found ‘100% Effective in Preventing Severe COVID-19 Cases’, Emergency Use Authorisation Sought From FDA
“This positive primary analysis confirms the ability of our vaccine to prevent COVID-19 disease with 94.1% efficacy and importantly, the ability to prevent severe COVID-19 disease. We believe that our vaccine will provide a new and powerful tool that may change the course of this pandemic and help prevent severe disease, hospitalizations and death,” said Moderna CEO.
Washington, November 30: Massachusetts-headquartered biotechnology firm Moderna Inc, which is developing an mRNA-
“This positive primary analysis confirms the ability of our vaccine to prevent COVID-19 disease with 94.1% efficacy and importantly, the ability to prevent severe COVID-19 disease.”
They believe that their vaccine will help preventing more people getting infected and preventing from more deaths. They also thank to the thousands of volunteers that went trough Phase 1, Phase 2 and Phase 3 of the vaccine.
Moderna has submitted its request before the US Food and Drug Administrator (FDA), seeking emergency use authorisation (EUA) at the earliest. The grant of emergency use permit would be the first step before the roll-out of vaccine for the general populace.